Literature DB >> 10331607

Learning and memory in the FMR1 knockout mouse.

G S Fisch1, H K Hao, C Bakker, B A Oostra.   

Abstract

The fragile X [fra(X)] syndrome is manifested phenotypically as a developmental disability comprised mainly of moderate-to-severe mental retardation (MR). Deficits are especially evident in auditory and visual short-term memory. Recently, an FMR1 knockout mouse developed by the Dutch-Belgian Fragile X Consortium demonstrated significantly lower visual-spatial abilities than littermate controls. We wondered if these results were associated with learning per se or to performance deficits only. Thus, we examined learning and memory in male FMR1 knockout mice crossbred from Fvb and E129 strains, and in male Fvb control mice, using operant conditioning techniques. In Experiment 1, we demonstrated that two aged male FMR1 knockouts could acquire the necessary bar-press response to discriminate visual (L+) and auditory (N+) stimuli. In Experiment 2, we showed that three naive male knockouts and two naive male controls, all 12 weeks old, also learned to discriminate L+ and N+. A third component, a complex discrimination task, during which light and noise were presented concurrently without reinforcement (LN-) was added to each session. All knockouts acquired both L+ and N+ discriminative responses in fewer sessions and with higher discrimination ratios than either control. Moreover, all knockouts exhibited the typical response pattern associated with complex discrimination (LN-) tasks. However, neither control made the complex discrimination. Our findings were unexpected and raise issues concerning FMR1 mouse strains and their cognitive-behavioral testing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331607     DOI: 10.1002/(sici)1096-8628(19990528)84:3<277::aid-ajmg22>3.0.co;2-w

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.

Authors:  Tao Su; Hong-Xing Fan; Tao Jiang; Wei-Wen Sun; Wei-Yi Den; Mei-Mei Gao; Sheng-Qiang Chen; Qi-Hua Zhao; Yong-Hong Yi
Journal:  Psychopharmacology (Berl)       Date:  2010-12-23       Impact factor: 4.530

2.  Olfactory discrimination learning in mice lacking the fragile X mental retardation protein.

Authors:  John Larson; Daniel Kim; Roseanne C Patel; Christina Floreani
Journal:  Neurobiol Learn Mem       Date:  2008-03-04       Impact factor: 2.877

3.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

4.  Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Randall L Carpenter; Richard Paylor
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

5.  Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses.

Authors:  Corinne M Spencer; Olga Alekseyenko; Shannon M Hamilton; Alexia M Thomas; Ekaterina Serysheva; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Autism Res       Date:  2011-01-25       Impact factor: 5.216

6.  Cellular distribution of the fragile X mental retardation protein in the mouse brain.

Authors:  Diego A R Zorio; Christine M Jackson; Yong Liu; Edwin W Rubel; Yuan Wang
Journal:  J Comp Neurol       Date:  2016-09-16       Impact factor: 3.215

7.  Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.

Authors:  Mei Qin; Julia Kang; Carolyn Beebe Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

8.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

9.  Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.

Authors:  M K King; R S Jope
Journal:  Genes Brain Behav       Date:  2013-08-29       Impact factor: 3.449

10.  Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.

Authors:  Eric W Fish; Michael C Krouse; Sierra J Stringfield; Jeffrey F Diberto; J Elliott Robinson; C J Malanga
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.